CDKN2A Gene Mutation
Information about Inherited Mutations
What is CDKN2A?
CDKN2A is a gene that helps control cell growth. People who are born with changes—called mutations—in their CDKN2A gene have an increased risk for certain types of cancer.
Which cancers are associated with a CDKN2A mutation?
People with an in CDKN2A have Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome. This mutation increases the risk for pancreatic cancer and melanoma. A small number of CDKN2A mutations may also increase the risk for nerve sheath tumors, sarcomas and other cancers.
Does everyone with a CDKN2A mutation develop cancer?
Although the lifetime risk for cancer with a CDKN2A mutation is high, not everyone with a mutation develops cancer. Following the guidelines for screening and prevention increases the chances of preventing cancer or catching it at its earliest and most treatable .
What can people with a CDKN2A mutation do?
Experts have created guidelines which estimate cancer risks and outline recommendations for managing these risks in people with a CDKN2A mutation.
There may be family planning concerns and options for people with an inherited CDKN2A mutation.
What can people with a CDKN2A mutation do?
Experts have created guidelines which estimate cancer risks and outline recommendations for managing these risks in people with a CDKN2A mutation.
There may be family planning concerns and options for people with an inherited CDKN2A mutation.
If you test positive for a CDKN2A mutation, you should inform your close blood relatives (first-, second-, and third-degree relatives) about your test results and encourage them to speak with a genetics expert.
More detailed information for people with inherited CDKN2A mutations is highlighted below.
Want to stay informed about related content?
Get notified when updated information becomes available.
SIGN UP FOR CONTENT UPDATES
Information for People with an Inherited CDKN2A Mutation
Cancer Risks
Cancer risk estimates are updated based on the latest research. Read about the lifetime risk for different cancers in people with inherited CDKN2A mutations.
Risk Management Options
Read about the latest expert guidelines for cancer screening and prevention for people with a CDKN2A mutation. Learn about research studies enrolling high-risk patients.
Cancer Treatment Options
Tumor biomarker testing and genetic testing can provide additional clues about which treatments may work best for your cancer. People who test positive for a CDKN2A mutation may have additional treatment or clinical trial options available to them.
Other Considerations
Learn additional information about inherited CDKN2A mutations and options related to family planning.
Participate in Research
The studies below are enrolling people with CDKN2A mutations. To search for more studies, visit our Search and Enroll Tool.
Screening Study for Pancreatic Cancer in People with Inherited Mutations
Clinicaltrials.gov identifier: NCT05058846
Pancreatic Cancer Early Detection for People at High Risk
Clinicaltrials.gov identifier: NCT04970056
